Filtros de búsqueda

Lista de obras de Claudia Maggi

Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation.

artículo científico publicado en 2013

Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study.

artículo científico publicado en 2017

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer

artículo científico publicado en 2015

Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study

article

Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies

artículo científico publicado en 2014

Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS-BRAF wild-type colorectal cancer receiving cetuximab or panitumumab.

artículo científico publicado en 2015

Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer: A systematic review and meta-analysis of published trials

artículo científico publicado en 2015

DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan

artículo científico publicado en 2015

Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer

artículo científico publicado en 2015

FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma

artículo científico publicado en 2014

Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.

artículo científico publicado en 2016

First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis

artículo científico publicado en 2015

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study

artículo científico publicado en 2016

Gain of ALK gene copy number may predict lack of benefit from anti-EGFR treatment in patients with advanced colorectal cancer and RAS-RAF-PI3KCA wild-type status

artículo científico publicado en 2014

Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trials

artículo científico publicado en 2014

Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases

article

Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis

artículo científico publicado en 2015

Role of cMET in the development and progression of colorectal cancer

artículo científico publicado en 2013

Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens: Clinical outcome and biomarkers of efficacy

scientific article published on 04 September 2013

TP53 mutations in advanced colorectal cancer: the dark side of the moon.

artículo científico

Treatment of elderly patients with metastatic renal cell carcinoma

artículo científico publicado en 2015

Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda